Analyst Ratings for Infinity Pharmaceutical (INFI) [Neutrals]

INFI Rating Summary

INFI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on INFI
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $21.17 (+99.7%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/8/2014 Nomura Securities New Coverage Neutral
(N/A)
14.00
(N/A)
12.50 10.60 -15.2% Details
12/12/2013 Credit Suisse Downgrade Neutral
(Outperform)
20.00
(N/A)
13.31 10.60 -20.36% Details
Like INFI Ratings? Also take a look at WAG, GILD

INFI Ratings News